Predicting risk of progression to lower respiratory tract infection in allogeneic hematopoietic cell transplant recipients with respiratory viral infections: where are we now?

Bone Marrow Transplant. 2022 May;57(5):701-702. doi: 10.1038/s41409-022-01616-7. Epub 2022 Feb 26.

Authors

Fareed Khawaja¹, Roy F Chemaly²

Affiliations

¹ Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. [email protected].

No abstract available

MeSH terms

Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Respiratory Syncytial Virus Infections*
Respiratory Tract Infections* / etiology
Retrospective Studies
Transplant Recipients
Transplantation, Homologous
Virus Diseases*